SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/257A1F5EC956E42DE25053908F9C2E835E6D075499413A5878A7B6E7FF48FE21CBA3AA5AC6059DFCB9F86087F5218752>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/257A1F5EC956E42DE25053908F9C2E835E6D075499413A5878A7B6E7FF48FE21CBA3AA5AC6059DFCB9F86087F5218752
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/257A1F5EC956E42DE25053908F9C2E835E6D075499413A5878A7B6E7FF48FE21CBA3AA5AC6059DFCB9F86087F5218752
http://www.w3.org/2000/01/rdf-schema#comment
"the quantitative level of mutant T315I allele is predictive of major molecular response at 12 months on second-line nilotinib or dasatinib treatment."
xsd:string
http://purl.uniprot.org/uniprot/#_A25A0FE8DBACCA27F445FB901896F7A1A5E0DAB10CCDE3F1502ACB2F21B870AC4A0B7F9B9574519ACDC90FAF06DE3CC2
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/257A1F5EC956E42DE25053908F9C2E835E6D075499413A5878A7B6E7FF48FE21CBA3AA5AC6059DFCB9F86087F5218752
http://purl.uniprot.org/uniprot/Q6QJE6
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/257A1F5EC956E42DE25053908F9C2E835E6D075499413A5878A7B6E7FF48FE21CBA3AA5AC6059DFCB9F86087F5218752
http://purl.uniprot.org/uniprot/#_Q6QJE6-mappedCitation-23065514
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/257A1F5EC956E42DE25053908F9C2E835E6D075499413A5878A7B6E7FF48FE21CBA3AA5AC6059DFCB9F86087F5218752